Azido-PEG1-azide

CAS No. 24345-74-2

Azido-PEG1-azide( —— )

Catalog No. M24118 CAS No. 24345-74-2

Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azido-PEG1-azide
  • Note
    Research use only, not for human use.
  • Brief Description
    Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24345-74-2
  • Formula Weight
    156.15
  • Molecular Formula
    C4H8N6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [N-]=[N+]=NCCOCCN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • Amino-PEG4-Boc

    Amino-PEG4-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • MS4077

    MS4077 is a novel PROTAC (degrader) of ALK, potently decreases cellular levels of oncogenic active ALK fusion proteins in a concentration- and time-dependent manner in SU-DHL-1 lymphoma and NCI-H2228 lung cancer cells (DC50=3 nM).

  • Gefitinib-based PROT...

    Gefitinib-based PROTAC 3 is a VHL-recruiting PROTAC that induces the degradation of EGFR and EGFR mutants with DC50 of 11.7 nM and 22.3 nM for HCC827 cell (Exon 19 del) and H3255 cell (L858R).